| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | +74.1% | +67.2% |
| R&D Expense | $756K | +15.2% | +105.6% |
| SG&A Expense | $815K | +23.9% | +9.3% |
| Operating Income | -$545K | +24.8% | -9.1% |
| Income Tax | $0 | — | — |
| Net Income | -$510K | +26.0% | -16.8% |
| EPS (Basic) | -$0.33 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $5.1M | -5.3% | -27.9% |
| Total Assets | $5.1M | -5.3% | -37.0% |
| Current Liabilities | $1.1M | +23.1% | +10.1% |
| Total Liabilities | $1.1M | +23.1% | +10.1% |
| Stockholders' Equity | $4.0M | -11.1% | -43.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.0M | — | — |
| -17.9% |
| EPS (Diluted) | -$0.33 | +26.7% | -17.9% |